Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$1.32B |
| 2 |
Eli Lilly
LLY
|
+$1.17B |
| 3 |
Baxter International
BAX
|
+$1,000M |
| 4 |
Amazon
AMZN
|
+$780M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$770M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.49B |
| 2 |
Apple
AAPL
|
+$1.21B |
| 3 |
Deere & Co
DE
|
+$1.07B |
| 4 |
American Tower
AMT
|
+$1.02B |
| 5 |
McDonald's
MCD
|
+$996M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.81% |
| 2 | Technology | 18.45% |
| 3 | Financials | 13.39% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 10.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Fox Factory Holding Corp
FOXF
$886M
| $95.4M | 0.02% |
902,855
-58,008
| -6% | -$5.27M |
|
|
DRNA
602
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $95.1M | 0.02% |
4,317,623
-578,530
| -12% | -$12.7M |
|
603
Steven Madden
SHOO
$3.55B
| $94.8M | 0.02% |
2,682,756
-2,763,271
| -51% | -$78.6M |
|
604
3M
MMM
$94.3B
| $94M | 0.02% |
643,411
-1,415,525
| -69% | -$201M |
|
605
Onto Innovation
ONTO
$15.3B
| $93.3M | 0.02% |
1,961,529
-960,604
| -33% | -$38.5M |
|
|
RVNC
606
DELISTED
Revance Therapeutics, Inc.
RVNC
| $92.6M | 0.02% |
3,268,117
-294,474
| -8% | -$7.63M |
|
607
Hanover Insurance
THG
$7.98B
| $92.5M | 0.02% |
790,902
+36,872
| +5% | +$3.98M |
|
608
ING
ING
$102B
| $92.5M | 0.02% |
9,795,089
-617,973
| -6% | -$5.3M |
|
609
Gentex
GNTX
$5.07B
| $92.4M | 0.02% |
2,724,095
-199,263
| -7% | -$6.14M |
|
610
Ultragenyx Pharmaceutical
RARE
$2.55B
| $92.4M | 0.02% |
667,187
-86,437
| -11% | -$10.3M |
|
|
CTB
611
DELISTED
Cooper Tire & Rubber Co.
CTB
| $92.2M | 0.02% |
2,275,912
-289,383
| -11% | -$11M |
|
612
SLM Corp
SLM
$5.15B
| $92.1M | 0.02% |
7,433,027
-2,594,594
| -26% | -$27.3M |
|
613
Darden Restaurants
DRI
$24.4B
| $92.1M | 0.02% |
+773,104
| New | +$82.8M |
|
614
Belden
BDC
$5.19B
| $91.8M | 0.02% |
2,190,899
-116,948
| -5% | -$4.32M |
|
615
Vail Resorts
MTN
$5.3B
| $91.1M | 0.02% |
326,649
-97,419
| -23% | -$25.2M |
|
616
Lantheus
LNTH
$6.59B
| $91M | 0.02% |
6,748,734
+1,687,999
| +33% | +$22.1M |
|
617
Idexx Laboratories
IDXX
$46.2B
| $90.8M | 0.02% |
181,745
-142,344
| -44% | -$63.7M |
|
|
SYNH
618
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $90.8M | 0.02% |
1,333,321
+1,199,797
| +899% | +$74.8M |
|
619
Cabot Corp
CBT
$4.52B
| $89.7M | 0.02% |
1,998,909
-31,621
| -2% | -$1.31M |
|
620
Arista Networks
ANET
$238B
| $89.6M | 0.02% |
4,932,976
+4,913,296
| +24,966% | +$77.9M |
|
621
Installed Building Products
IBP
$6.49B
| $88.5M | 0.02% |
868,504
-116,086
| -12% | -$11.9M |
|
|
WLL
622
DELISTED
Whiting Petroleum Corporation
WLL
| $88.3M | 0.02% |
3,532,204
+407,099
| +13% | +$8.17M |
|
|
GBT
623
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $88.3M | 0.02% |
2,038,120
-220,075
| -10% | -$10.9M |
|
624
Hexcel
HXL
$7.82B
| $88.2M | 0.02% |
1,818,668
-420,383
| -19% | -$18.3M |
|
625
Albany International
AIN
$1.78B
| $88M | 0.02% |
1,198,349
-52,339
| -4% | -$3.3M |
|
Similar funds
Wellington Management Group's Q4 2020 Portfolio in Review
As of Q4 2020, Wellington Management Group held 2,079 positions worth $543B, up 12% from $483B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Wellington Management Group's Q4 2020 filing shows 206 new, 660 increased, 944 reduced and 175 closed positions. Its largest new stake was Unilever: 9,037,603 shares worth $614M. The largest sale was Intel, an estimated $1.49B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q4 2020 buy was Unilever: 9,037,603 shares worth $614M.
- Wellington Management Group added most to Morgan Stanley in Q4 2020, an estimated $1.32B increase.
- Wellington Management Group's biggest Q4 2020 reduction was Intel, cutting an estimated $1.49B.
- Wellington Management Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $622M.
- Wellington Management Group's ten largest holdings make up 17% of its $543B portfolio in Q4 2020.
- Wellington Management Group opened 206 new positions and closed 175 in Q4 2020.
- Wellington Management Group's portfolio value rose 12% quarter-over-quarter to $543B.
Based on Wellington Management Group's 13F filing for Q4 2020, filed 12 Feb 2021.